These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8445093)

  • 1. Vitamin E as an adjuvant in an Escherichia coli J5 vaccine.
    Hogan JS; Weiss WP; Smith KL; Todhunter DA; Schoenberger PS; Williams SN
    J Dairy Sci; 1993 Feb; 76(2):401-7. PubMed ID: 8445093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adjuvants on safety and efficacy of an Escherichia coli J5 bacterin.
    Hogan JS; Cannon VB; Smith KL; Rinehart C; Miller S
    J Dairy Sci; 2005 Feb; 88(2):534-42. PubMed ID: 15653518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intramammary immunization with an Escherichia coli J5 bacterin.
    Smith JL; Hogan JS; Smith KL
    J Dairy Sci; 1999 Dec; 82(12):2582-8. PubMed ID: 10629804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial.
    Hogan JS; Weiss WP; Todhunter DA; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Feb; 75(2):415-22. PubMed ID: 1560136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two commercially available Escherichia coli J5 vaccines against E. coli intramammary challenge.
    Tomita GM; Ray CH; Nickerson SC; Owens WE; Gallo GF
    J Dairy Sci; 2000 Oct; 83(10):2276-81. PubMed ID: 11049068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of antibody titers to intramammary immunization with Escherichia coli J5 bacterin.
    Hogan JS; Smith KL; Schoenberger P; Romig S; Thompson L
    J Dairy Sci; 1997 Oct; 80(10):2398-402. PubMed ID: 9361212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an Escherichia coli J5 vaccine on mild clinical coliform mastitis.
    Hogan JS; Weiss WP; Smith KL; Todhunter DA; Schoenberger PS; Sordillo LM
    J Dairy Sci; 1995 Feb; 78(2):285-90. PubMed ID: 7745148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
    Wise AJ; Hogan JS; Takemura K; Smith KL
    J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of immunization with ferric citrate receptor FecA from Escherichia coli on induced coliform mastitis.
    Takemura K; Hogan JS; Lin J; Smith KL
    J Dairy Sci; 2002 Apr; 85(4):774-81. PubMed ID: 12018422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine.
    Hogan JS; Smith KL; Todhunter DA; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):78-84. PubMed ID: 1541745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an Escherichia coli J5 bacterin administered to primigravid heifers.
    Hogan JS; Bogacz VL; Aslam M; Smith KL
    J Dairy Sci; 1999 May; 82(5):939-43. PubMed ID: 10342231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of route of vaccine administration against experimental intramammary infection caused by Escherichia coli.
    Tomita GM; Nickerson SC; Owens WE; Wren B
    J Dairy Sci; 1998 Aug; 81(8):2159-64. PubMed ID: 9749381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.
    González RN; Cullor JS; Jasper DE; Farver TB; Bushnell RB; Oliver MN
    Can J Vet Res; 1989 Jul; 53(3):301-5. PubMed ID: 2670166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-dihydroxyvitamin D3 enhances milk antibody titers to Escherichia coli J5 vaccine.
    Reinhardt TA; Stabel JR; Goff JP
    J Dairy Sci; 1999 Sep; 82(9):1904-9. PubMed ID: 10509248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milk and serum J5-specific antibody responses, milk production change, and clinical effects following intramammary Escherichia coli challenge for J5 vaccinate and control cows.
    Wilson DJ; Mallard BA; Burton JL; Schukken YH; Gröhn YT
    Clin Vaccine Immunol; 2007 Jun; 14(6):693-9. PubMed ID: 17460115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of changes in number of doses and anatomic location for administration of an Escherichia coli bacterin on serum IgG1 and IgG2 concentrations in dairy cows.
    Erskine RJ; Brockett AR; Beeching ND; Hull RW; Bartlett PC
    Am J Vet Res; 2010 Jan; 71(1):120-4. PubMed ID: 20043791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Oct; 78(10):2178-85. PubMed ID: 8598402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the efficacy of different adjuvants in live stock specific bacterial vaccines for turkeys against Bordetella infection and onset of antibody titers in respect to the age of the turkey poults.
    Glünder G; van der Ven H; Foulman A
    Pol J Vet Sci; 2004; 7(2):77-81. PubMed ID: 15230536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramammary challenge with Escherichia coli following immunization with a curli-producing Escherichia coli.
    Todhunter DA; Smith KL; Hogan JS; Nelson L
    J Dairy Sci; 1991 Mar; 74(3):819-25. PubMed ID: 2071713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.